The mechanism of timolol in lowering intraocular pressure. In the normal eye

R. L. Coakes and R. F. Brubaker

A single-drop, double-masked, randomized, placebo-controlled study of the mechanism of the ocular-pressure lowering property of timolol maleate, a beta-adrenergic blocker, was carried out in 23 normal subjects, using fluorophotometry. Timolol suppressed aqueous formation in all subjects. The range of suppression was 13% to 48%, with a mean +/- SD of 34% +/- 9%. The drug had no effect on anterior chamber volume or endothelial permeability to fluorescein and, apparently, had no effect on outflow resistance. No differences were observed between its effect on men and women or between eyes with light and dark irides.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Intraocular Pressure-Lowering Effects and Safety of Topical Administration of a Selective ROCK Inhibitor, SNJ-1656, in Healthy Volunteers
Tanihara et al.
Arch Ophthalmol 2008;126:309-315.
ABSTRACT | FULL TEXT  

Effects of Timolol on MYOC, OPTN, and WDR36 RNA Levels
Rozsa et al.
Arch Ophthalmol 2008;126:86-93.
ABSTRACT | FULL TEXT  

Evaluation of the beta2-Adrenergic Receptor Gene as a Candidate Glaucoma Gene in 2 Ancestral Populations
McLaren et al.
Arch Ophthalmol 2007;125:105-111.
ABSTRACT | FULL TEXT  

Effects of Topical Hypotensive Drugs on Circadian IOP, Blood Pressure, and Calculated Diastolic Ocular Perfusion Pressure in Patients with Glaucoma.
Quaranta et al.
IOVS 2006;47:2917-2923.
ABSTRACT | FULL TEXT  

Effect of cAMP on Porcine Ciliary Transepithelial Short-Circuit Current, Sodium Transport, and Chloride Transport
Ni et al.
IOVS 2006;47:2065-2074.
ABSTRACT | FULL TEXT  

A comparison of the fixed combination of latanoprost and timolol with the unfixed combination of brimonidine and timolol in patients with elevated intraocular pressure. A six month, evaluator masked, multicentre study in Europe
Garcia-Sanchez et al.
Br. J. Ophthalmol. 2004;88:877-883.
ABSTRACT | FULL TEXT  

A 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension
Diestelhorst and Larsson
Br. J. Ophthalmol. 2004;88:199-203.
ABSTRACT | FULL TEXT  

Nitric Oxide Attenuates {alpha}2-Adrenergic Receptors by ADP-ribosylation of Gi{alpha} in Ciliary Epithelium
Moroi et al.
IOVS 2001;42:2056-2062.
ABSTRACT | FULL TEXT  

Aqueous Humor Flow in Normal Human Eyes Treated With Brimonidine and Timolol, Alone and in Combination
Larsson
Arch Ophthalmol 2001;119:492-495.
ABSTRACT | FULL TEXT  

Comparison of the Early Effects of Brimonidine and Apraclonidine as Topical Ocular Hypotensive Agents
Maus et al.
Arch Ophthalmol 1999;117:586-591.
ABSTRACT | FULL TEXT  

{beta}-Blocker-Induced Complications and the Patient With Glaucoma: Newer Treatments to Help Reduce Systemic Adverse Events
Stewart and Garrison
Arch Intern Med 1998;158:221-226.
FULL TEXT